DOI: 10.1007/s00259-017-3707-3Pages: 1783-1786

The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy

1. Foundation IRCCS Istituto Nazionale Tumori, Nuclear Medicine Division

2. Lund University, Department of Medical Radiation Physics

3. Royal Marsden Hospital & Institute of Cancer Research, Joint Department of Physics

4. Université Catholique de Louvain, Nuclear Medicine, Molecular Imaging, Radiotherapy and Oncology Unit (MIRO), IECR

5. Ghent University, Department of Basic Medical Sciences, Division of Medical Physics

6. University of Würzburg, Department of Nuclear Medicine

7. Radboud University Medical Centre (RadboudUMC), Department of Radiology and Nuclear Medicine

8. LUNAM Université, Oniris, «AMaROC»

9. Université Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse

10. Laboratory of Medical Physics and Expert Systems, National Cancer Institute Regina Elena

11. Department of Radiology and Nuclear Medicine Erasmus MC

Correspondence to:
C. Chiesa
Tel: +39 02 2390 2023
Email: carlo.chiesa@istitutotumori.mi.it

Close

Abstract

This article is freely available, click here to access the full text/PDF

  • Accepted: Apr 16, 2017
  • Online: May 24, 2017

Article Tools

eanm
EJNMMI Ad